In this study, we will assess spatiotemporal gait parameters and fall risk in cancer survivors with chemotherapy-induced peripheral neuropathy in comparison with healthy individuals
- Conditions
- Health Condition 1: G988- Other disorders of nervous system
- Registration Number
- CTRI/2021/09/036320
- Lead Sponsor
- Amarjyoti Institue of physiotherapy
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
• AGE CRITERIA
Group A (Cancer survivors) - 18 to 60 years
Group B (Healthy individuals) - 18 to 60 years
• Physician confirmed the diagnosis of cancer
• All types of cancer
• Both gender
• Received neo-adjuvant or adjuvant chemotherapy treatment
• Able to walk for at least 10 feet.
• Hereditary peripheral neuropathy .{ eg, Charcot-marie-tooth disease}
• Treatment with antiepileptic drugs, antidepressants and major analgesics.
• Orthopaedic problem that affect balance { eg ACL reconstruction}
• Vestibular disorder and Visual acuity problem .
• Neurological conditions like Parkinsonâ??s disease , Ataxia
• Chronic inflammatory demyelinating polyneuropathy
• Concomitant Disease like diabetes, renal insufficiencies
• Prior history of alcohol abuse
• Lower limb amputee.
• Use of walking aid
• CIPN negative or Asymptomatic
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method â?¢ Step length <br/ ><br>â?¢ Width of BOS <br/ ><br>â?¢ Degree Of toe out <br/ ><br>â?¢ Cadence <br/ ><br>â?¢ Stride length <br/ ><br>â?¢ Walking velocity <br/ ><br> <br/ ><br>Timed up and go test [ TUG Test ]Timepoint: After screening on Day 1 cancer survivorâ??s and healthy individualâ??s spatiotemporal gait parameters and fall risk will be assessed then Later they will get compared between the obtained values of cancer survivorâ??s parameters the Normal parameters of healthy individuals
- Secondary Outcome Measures
Name Time Method oneTimepoint: None